Photocatalytic semiconductor-based nanoreactors, that convert nontoxic mole cules into toxic ones for cancer therapy, have attracted great interest. However, its therapeutic efficiency is limited by the fast electron-hole recombination within a narrow bandgap, low oxidative damage of H 2 O 2 , and tumor hypoxia. Herein, aggregation-limited hemin is introduced onto Bi 2 Se 3 nanoparticles for successively solving these problems. The nanoreactor (Bi 2 Se 3 @ hemin-(G-H)-HA NPs) is obtained through adamantane modified hemin and β-cyclodextrin modified hyaluronic acid complexing and wrapping on Bi 2 Se 3 NPs via host-guest and electrostatic interaction. Once irradiated by NIR light, the hemin assists Bi 2 Se 3 to separate electron-hole pairs and catalyze endogenous H 2 O to generate vast H 2 O 2 , resulting in a 3.9-fold higher H 2 O 2 generation than that of individual Bi 2 Se 3. Subsequently, H 2 O 2 is catalyzed by aggregation-limited hemin to generate highly toxic •OH and •O 2 − , which improves the total reactive oxygen species generation of Bi 2 Se 3 @hemin-(G-H)-HA by 10.8-fold compared to that of Bi 2 Se 3 NPs. Importantly, the cytotoxicity result exhibits a death rate of HepG2 cells of above 90%, even though in a simulated hypoxic environment. Additionally, the in vivo result indicates this nanoreactor realizes an synergetic anticancer effect with a tumor inhibition rate of 92.3%. Overall, such a nanoreactor with hemin-assisted cascade catalysis is a promising candidate for improving therapeutic efficacy.